Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Non-Current Liabilities (2020 - 2024)

Historic Total Non-Current Liabilities for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $3.9 million.

  • Burning Rock Biotech's Total Non-Current Liabilities fell 6534.39% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 6534.39%. This contributed to the annual value of $5.2 million for FY2024, which is 35164.08% up from last year.
  • Per Burning Rock Biotech's latest filing, its Total Non-Current Liabilities stood at $3.9 million for Q3 2025, which was down 6534.39% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Total Non-Current Liabilities registered a high of $38.2 million during Q4 2021, and its lowest value of $1.2 million during Q4 2023.
  • Its 5-year average for Total Non-Current Liabilities is $7.8 million, with a median of $5.2 million in 2024.
  • As far as peak fluctuations go, Burning Rock Biotech's Total Non-Current Liabilities skyrocketed by 5087600.0% in 2021, and later plummeted by 9329.62% in 2022.
  • Over the past 5 years, Burning Rock Biotech's Total Non-Current Liabilities (Quarter) stood at $38.2 million in 2021, then crashed by 93.3% to $2.6 million in 2022, then tumbled by 54.82% to $1.2 million in 2023, then skyrocketed by 351.64% to $5.2 million in 2024, then dropped by 26.2% to $3.9 million in 2025.
  • Its Total Non-Current Liabilities stands at $3.9 million for Q3 2025, versus $4.3 million for Q2 2025 and $4.2 million for Q1 2025.